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Pulmonary Vein Isolation as an End Point for Left
trial Circumferential Ablation of Atrial Fibrillation
ristina Lemola, MD, Hakan Oral, MD, FACC, Aman Chugh, MD, Burr Hall, MD,
eter Cheung, MD, Jihn Han, MD, Kamala Tamirisa, MD, Eric Good, DO, Frank Bogun, MD,
rank Pelosi, JR, MD, FACC, Fred Morady, MD, FACC
nn Arbor, Michigan
OBJECTIVES We sought to determine whether elimination of pulmonary vein (PV) arrhythmogenicity is
necessary for the efficacy of left atrial circumferential ablation (LACA) for atrial fibrillation
(AF).
BACKGROUND The PVs often provide triggers or drivers of AF. It has been shown that LACA is more
effective than PV isolation in eliminating paroxysmal AF. However, it is not clear whether
complete PV isolation is necessary for the efficacy of LACA.
METHODS In 60 consecutive patients with paroxysmal (n 39) or chronic (n 21) AF (mean age 53 12
years), LACA to encircle the left- and right-sided PVs, with additional lines in the posterior
left atrium and along the mitral isthmus, was performed under the guidance of an
electroanatomic navigation system. The PVs were mapped with a decapolar ring catheter
before and after LACA. If PV isolation was incomplete, no attempts at complete isolation
were made.
RESULTS After LACA, there was incomplete electrical isolation of one or more PVs in 48 (80%) of the
60 patients. The prevalence of PV tachycardias was 82% before and 8% after LACA (p 
0.001). At 11  1 months of follow-up, 10 (83%) of the 12 patients with complete and 39
(81%) of 48 patients with incomplete PV isolation were free from recurrent AF without
antiarrhythmic drug therapy (p  1.0). A successful outcome was not related to the number
of completely isolated PVs per patient (p  0.6).
CONCLUSIONS Left atrial circumferential ablation modifies the arrhythmogenic substrate within the PVs.
Complete electrical isolation of the PVs is not a requirement for a successful outcome after
LACA. (J Am Coll Cardiol 2005;46:1060–6) © 2005 by the American College of
ublished by Elsevier Inc. doi:10.1016/j.jacc.2005.05.069Cardiology Foundation
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irrhythmogenic foci within the pulmonary veins (PVs)
ften initiate and/or perpetuate an episode of atrial fibrilla-
ion (AF) (1–3), providing the rationale for PV isolation as
method of eliminating AF (4–7). However, the mecha-
isms of AF are multifactorial (8), and AF also may be
riven by mechanisms independent of the PVs. A recent
tudy demonstrated that left atrial circumferential ablation
LACA) to encircle the PVs is more effective than PV
solation in patients with paroxysmal AF (9). The extent to
hich the efficacy of LACA depends on PV isolation is not
ell established.
The purpose of this prospective study was to determine
he effects of LACA on the arrhythmogenic activity of the
Vs and to determine whether the clinical efficacy of LACA
epends on PV isolation.
ETHODS
tudy subjects. The subjects of this study were 60 consec-
tive patients who underwent LACA for paroxysmal (n 
9) or chronic AF (n  21). The mean age of the patients
as 53  12 years. There were 50 men and 10 women.
trial fibrillation was first diagnosed 6  6 years before
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ccepted May 13, 2005.ACA. The patients with paroxysmal AF experienced 12
7 episodes of AF per month. The duration of the most
ecent episode of AF in patients with chronic AF was 13 
months. Structural heart disease was present in nine
atients (15%), coronary artery disease in five, and hyper-
ensive heart disease in four. The mean left ventricular
jection fraction was 0.55 0.08. The mean left atrial (LA)
iameter was 41  5 mm in patients with paroxysmal AF
nd 47  6 mm in patients with chronic AF (p  0.01).
ther demographic and clinical characteristics were similar
mong patients with paroxysmal and chronic AF.
lectrophysiologic study. All patients provided written,
nformed consent. All antiarrhythmic medications except
miodarone were discontinued four to five half-lives
efore the procedure. Vascular access was obtained
hrough a femoral vein. A quadripolar electrode catheter
EP Technologies, San Jose, California) was positioned
ithin the coronary sinus (CS). After trans-septal punc-
ure, heparin was infused to maintain an activated clotting time
f 275 to 350 s. A decapolar circular catheter (Lasso, Biosense-
ebster, Diamond Bar, California) and a temperature-
ontrolled 8-mm-tip quadripolar catheter (Navistar,
iosense-Webster) were advanced into the LA and used for
apping and ablation.
Bipolar and unipolar electrograms were recorded dig-
tally at a bandpass of 30 to 500 Hz and 0.5 to 200 Hz,
espectively (EPMed Systems, West Berlin, New Jersey).
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September 20, 2005:1060–6 Pulmonary Vein Isolationtrial pacing was performed from the CS with a stimu-
ator (EPMed Systems, Clinical Stimulator model EP-3).
adiofrequency (RF) catheter ablation. Radiofrequency
atheter ablation was performed after construction of the
A shell and PVs using an electroanatomic mapping system
CARTO, Biosense-Webster), as previously described (10).
blation was performed during AF to encircle the left- and
ight-sided PVs 1 to 2 cm from the PV ostia. When there
as a narrow rim of tissue between the left-sided PVs and
he LA appendage, ablation was performed at the base of
he ostium of the PV. Additional lines were created in the
osterior LA between the two encircling lesions and also
long the mitral isthmus from the inferior aspect of the left
nferior PV to the mitral annulus (Fig. 1). Completeness of
onduction block across these lines was not assessed.
Radiofrequency energy was delivered at a maximum
ower output of 70 W and a target temperature of 55°C for
0 to 40 s at each site. The end point of ablation at each site
as an 80% decrease in the local electrogram amplitude or
0 s of energy application, whichever came first. If there was
o change in the electrogram amplitude after 40 s of RF
igure 1. Left atrial (LA) circumferential ablation. Shown is the pos-
eroanterior projection of the LA. Ablation lines encircle the left- and
ight-sided pulmonary veins (PV), and there are additional ablation lines in
Abbreviations and Acronyms
AF  atrial fibrillation
CS  coronary sinus
LA  left atrium/atrial
LACA  left atrial circumferential ablation
PV  pulmonary vein
RF  radiofrequencyf
he posterior LA and along the mitral isthmus. LI left inferior; LS left
uperior; RI  right inferior; RS  right superior.nergy application, the catheter was moved to a new site.
fter completion of the encircling lesions, the area within
he circles, outside the PVs, was mapped, and in 60% of
atients, sites where the local atrial electrogram amplitude
as 0.2 mV were found. Individual applications of RF
nergy were delivered at these sites using the same end
oints as during creation of the ablation lines. In addition,
hen AF was still present, sites inside the encircling
blation lines where the cycle length was shorter than the
trial cycle length in the CS also were ablated.
The mean duration of RF energy application was 39 12
in, and the mean procedure and fluoroscopy times were
92  39 and 50  11 min, respectively. None of the
atients had an acute complication.
After the ablation procedure, the patients were observed
n a monitored hospital bed overnight and anticoagulated
ith heparin. All patients were anticoagulated with warfarin
or three months or longer after the procedure. In patients
ho were treated with an antiarrhythmic medication before
he procedure, treatment with the same drug was continued
or eight to 12 weeks after the procedure.
tudy protocol. The study protocol was approved by our
nstitutional Review Board. Before ablation, a decapolar
ircular mapping catheter (Lasso, Biosense-Webster) was
nserted into the LA through the original trans-septal
uncture site. Each PV was mapped for the presence of PV
otentials during sinus rhythm and during CS pacing. In
he patients who presented in sinus rhythm, AF was
nduced by rapid atrial pacing. Each PV was mapped for the
resence of PV tachycardias, defined as rapid electrical
ctivity within a PV with a cycle length shorter than that in
he adjacent LA or CS (Fig. 2) (2,3). The ring catheter then
as removed from the LA, and LACA was performed
uring AF.
After LACA, the ring catheter was again inserted into
he LA and used to re-map each PV during sinus rhythm,
uring CS pacing, and during an induced episode of AF.
esidual PV potentials were not ablated, and complete
solation of the PVs was not attempted.
Complete PV isolation was defined as the absence of PV
otentials at each electrode of the decapolar ring catheter
ositioned at the ostium of the PVs, as well as complete
ntrance block into a PV during sinus rhythm and an
nduced episode of AF. The interval between the CS pacing
timulus and PV potentials recorded at the PV ostium was
easured off-line using digital calipers.
ollow-up. All patients were seen in an outpatient clinic
wo to three months after the procedure and every six
onths thereafter. The patients were contacted by a nurse
ractitioner every two months and questioned about symp-
oms. In addition, patients were asked to contact the nurse
ractitioner whenever they experienced symptoms. In the
vent of any symptoms suggestive of AF, the patient was
iven an event monitor to document the cause of symptoms.
o patient was lost to follow-up, and the mean duration ofollow-up was 11 1 months. Because recurrences of AF or
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Pulmonary Vein Isolation September 20, 2005:1060–6trial flutter within the first weeks after ablation may be
ransient (11), a blanking period of six weeks was applied.
tatistical analysis. Continuous variables are expressed as
he mean value  SD and were compared by the Student t
est. The change in stimulus-to-PV potential intervals was
nalyzed with the paired t test. Categorical variables were
ompared by chi-square analysis or with the Fisher exact test
hen n was 5. Freedom from recurrent AF was deter-
ined by Kaplan-Meier analysis with the log-rank test. A
 0.05 indicated statistical significance.
ESULTS
ulmonary vein potentials before and after LACA. Be-
ore LACA, PV potentials were recorded in 213 (94%) of
he 226 PVs. The PV potentials were present in one or more
Vs in all 60 patients (100%). After LACA, there were PV
otentials indicative of one or more functioning PV fascicles
n 37 (63%) of the 59 left superior PVs, 31 (58%) of the 53
eft inferior PVs, 33 (56%) of the 59 right superior PVs, and
igure 2. An example of a pulmonary vein (PV) tachycardia. Shown are ele
ing catheter positioned at the ostium of a left superior PV (L1-2, . . ., L10-
ycle length of the PV tachycardia was 110 ms, and the cycle length with5 (32%) of the 47 right inferior PVs. Overall, there was ancomplete electrical isolation of one or more PVs in 48
80%) of the 60 patients after LACA (Fig. 3).
The mean of the shortest interval between the stimulus
nd PV potentials recorded at the PV ostium during pacing
rom the CS increased by 41 40% (from 83 22 ms to 117
38 ms; p  0.01) (Fig. 4).
ulmonary vein tachycardias before and after LACA.
mong the 60 patients, PV tachycardias were recorded in
ne or more PVs in 49 (82%) before and in five patients
8%) after LACA (p  0.001).
The PV tachycardias had a mean cycle length of 149 
8 ms before LACA and 157  41ms after LACA (p 
.4). The simultaneous cycle length at the adjacent LA or
S was 200 37 ms before LACA and 336 270 ms after
ACA, respectively (p  0.01).
umber of completely isolated PVs and freedom from
ecurrent AF. At a mean follow-up of 11  1 months, 39
81%) of 48 patients with incomplete PV isolation and 10
83%) of 12 patients with complete PV isolation were in
inus rhythm in the absence of antiarrhythmic drug therapy
rdiographic leads I and V5, bipolar electrograms recorded with a decapolar
d electrograms recorded within the coronary sinus (CSd, CSp). The mean
CS was 245 ms.ctrocand had no further episodes of symptomatic AF (p  1.0,
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September 20, 2005:1060–6 Pulmonary Vein Isolationisher exact test). Both in patients with paroxysmal and
hronic AF, a successful outcome was independent of the
umber of PVs that were electrically isolated (p 0.6) (Fig. 5).
ulmonary vein isolation and LA flutter. Among the 60
atients, 10 (17%) developed LA flutter after LACA. There
ere residual PV potentials in 7 (70%) of the 10 patients
ith LA flutter and in 41 (82%) of the 50 patients without
igure 3. Prevalence of pulmonary vein (PV) potentials before (open bars)
nd after (solid bars) left atrial circumferential ablation. Other abbrevia-
ions as in Figure 1.igure 4. Effect of left atrial circumferential ablation (LACA) on activation of p
s the shortest stimulus-to-PV potential interval recorded in the same left superA flutter (p  0.4, Fisher exact test). Four patients in
hom LA flutter persisted beyond three months underwent
uccessful ablation of the atrial flutter. The successful
blation site was the mitral isthmus in two patients, the LA
oof in one patient, and a gap in the ablation line encircling
he right pulmonary veins in one patient.
omplications. There were no complications in any of the
atients who participated in this study.
ISCUSSION
ain findings. With the techniques used in this study,
ACA for AF usually was associated with incomplete PV
solation. Although PV potentials were still present in at
east one PV in 80% of patients, there usually was a
onduction delay between the LA and PVs, and the
revalence of PV tachycardias was markedly reduced after
ACA. Most importantly, a successful outcome after
ACA was found to be independent of the number of PVs
hat were electrically isolated, and freedom from symptom-
tic AF during follow-up was just as likely when none of the
Vs were completely isolated as when all four PVs wereulmonary vein (PV) potentials during coronary sinus (CS) pacing. Shown
ior PV before (70 ms) (A) and after LACA (200 ms) (B).
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Pulmonary Vein Isolation September 20, 2005:1060–6solated. These results demonstrate that when LACA is
erformed during AF with the end points used in this study,
omplete electrical isolation of the PVs is not necessary for
successful outcome.
V isolation and freedom from recurrent AF. Previous
tudies have demonstrated that recurrent AF after PV
solation is associated with recurrent conduction through
reviously isolated PVs (12,13). However, in the present
tudy, many patients remained free of recurrent AF despite
he presence of incomplete PV isolation immediately after
ACA. Therefore, whereas the efficacy of PV isolation
epends on complete and lasting PV disconnection from the
A, the efficacy of LACA does not. This highlights the fact
hat LACA eliminates AF by mechanisms other than
omplete PV isolation. In addition, by targeting sites within
he encircling lesions where relatively rapid cycle lengths
ere observed during AF, the profibrillatory effects of PV
achycardias may have been eliminated, despite the fact that
omplete PV isolation was not achieved.
In a randomized study, LACA was found to be more
ffective than PV isolation by segmental ostial ablation in
atients with paroxysmal AF (10). It is likely that the
ncremental efficacy of LACA is attributable to mechanisms
f action that are independent of the PVs. These mecha-
isms of action may include LA compartmentalization (14),
limination of anchor points for rotors (14–16), and auto-
omic denervation (17). None of these mechanisms of
ction require complete PV isolation. Furthermore, a reduc-
ion in the prevalence or elimination of PV tachycardias
oes not require complete PV isolation. Therefore, the end
oints of voltage abatement and elimination of residual sites
isplaying relatively rapid cycle lengths used in the present
tudy appear to be adequate for achieving an acceptable
linical outcome.
A previous study demonstrated an excellent success rate
hen intraoperative RF ablation was performed using a
esion set that did not isolate the PVs (18). Furthermore,
ther investigators have demonstrated that recurrent AF
ften is eliminated after RF ablation that targets fraction-
igure 5. Freedom from recurrent atrial fibrillation (AF) and number of
ompletely isolated pulmonary veins (PVs). The probability of freedom
rom recurrent AF after left atrial circumferential ablation was unrelated to
he number of isolated PVs. The number of patients is shown within each bar.ted electrograms (19), with no attempts to isolate the PVs fr create lines of block. The results of these studies validate
he conclusion that PV isolation is not necessarily required
o eliminate AF.
V potentials and PV tachycardias. After LACA, although
esidual PV potentials were usually present, the prevalence
f PV tachycardias was markedly reduced. Therefore, al-
hough PV isolation was not complete, the arrhythmogenic
otential of the PVs was attenuated. Because PV tachycar-
ias are one of the factors that perpetuate an episode of AF
2,3), the reduction in PV tachycardias by LACA most
ikely contributed to the successful elimination of recurrent AF.
Atrial pacing in the CS demonstrated a conduction delay
etween the LA and PVs. A previous study demonstrated
hat there is a dynamic interplay between the LA and PVs,
nd that the occurrence of PV tachycardias usually requires
nput from the LA (2,20). Therefore, partial block of
mpulses from the LA into the PVs may have been one of
he reasons that PV tachycardias were much less prevalent
fter LACA. In addition, previous studies have shown that
omplete PV isolation is achievable with noncontiguous RF
nergy applications at the boundary of the PV antrum and
A (6). The RF lesions that were delivered 1 to 2 cm away
rom the ostia or at sites of relatively short cycle lengths
uring AF in the present study may have ablated some of
he arrhythmogenic fibers of the PV muscle sleeves.
These effects of LACA may result in modification of the
rrhythmogenic activity within the PVs. Furthermore, al-
hough complete conduction block across the encircling
esions may not be achieved, decremental conduction can
ccur, particularly at shorter cycle lengths, and may impede
he conduction of PV tachycardias to the LA.
A flutter. In a previous study, it was suggested that LA
utters can be prevented by complete ablation of all recov-
red fascicles during a repeat ablation procedure after LA
ntrum-PV disconnection (21). In this study, LA flutter
ccurred during follow-up in 17% of patients who under-
ent LACA, and the occurrence of LA flutter was not
elated to whether or not there was complete PV isolation.
revious studies have demonstrated that LA flutters after
ACA are usually macro–re-entrant and not related to
rrhythmogenic activity emanating from the PVs (22,23).
revious studies. In a previous study, 80% of patients
ho underwent PV isolation using a purely anatomic
pproach were free of recurrent AF during a mean
ollow-up of 16 months, regardless of whether PV isolation
as complete or not (24). In that study, ablation was
erformed at the ostium of the PVs rather than within the
A, and an 8-mm-tip catheter was used to look for PV
otentials. Complete PV isolation was defined as the
nability to capture the LA during pacing within a PV. In
ontrast, in the present study, the extent of PV isolation
fter LACA was assessed with a decapolar ring catheter,
hich is more likely to accurately detect residual PV
otentials than a standard 8-mm tip catheter.
In a recent study, circumferential PV isolation was notound to be superior to PV isolation by segmental ostial
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September 20, 2005:1060–6 Pulmonary Vein Isolationblation (25). No data on the relationship between the
ompleteness of PV isolation and clinical outcomes were
resented.
tudy limitations. A limitation of this study is that free-
om from AF during follow-up was based on patient-
eported symptoms, and asymptomatic episodes of AF may
ot have been detected. However, a previous study demon-
trated that asymptomatic recurrences of AF are rare in
atients with symptomatic paroxysmal AF who undergo
atheter ablation (26).
It is possible that PVs that were only partially isolated
mmediately after LACA became completely isolated dur-
ng follow-up because of post-ablation lesion maturation
nd progressive fibrosis. Because follow-up electrophysi-
logic procedures were not routinely performed, this possi-
ility cannot be ruled out.
onclusions. If ablation is performed during sinus rhythm
nd the only end point is PV isolation, the best outcomes
re achieved if there is complete isolation of all PVs (3,27).
urthermore, it is clear that if wide area circumferential
blation is performed during sinus rhythm, complete PV
solation is also the most desirable end point (28,29).
owever, when wide area circumferential ablation is per-
ormed during AF using end points of voltage abatement
nside the encircling lesions and elimination of sites display-
ng relatively short cycle lengths, complete PV isolation is
ot required for a successful outcome.
As long as PV stenosis is avoided, there are no deleterious
ffects of complete PV isolation. Nevertheless, because
omplete isolation requires additional time and RF energy
elivery, it is useful to know that complete elimination of
V potentials may not be necessary to achieve a successful
utcome with the type of wide area circumferential ablation
echnique used in the present study.
After this study was completed, esophageal injury result-
ng in atrioesophageal fistula formation was recognized as a
otential hazard of LACA (30,31). Because of this, the
echniques used in this study were modified, with elimina-
ion of the posterior wall ablation line, addition of an LA
oof line, reduction in the power and duration of RF energy
pplications on the posterior wall, and real-time visualiza-
ion of the esophagus with the use of barium paste (32).
urther studies are needed to establish the ablation tech-
ique with the best balance of efficacy and safety.
eprint requests and correspondence: Dr. Hakan Oral, Cardi-
logy, TC B1 140D, 1500 East Medical Center Drive, Ann
rbor, Michigan 48109-0311. E-mail: oralh@umich.edu.
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